jump to content jump to footer
Medical professional reviewing patient's MRI images on computer monitor with patient in MRI machine in background.
TGSE-BLADE demonstrated significantly reduced geometric distortion and artifacts caused by intracranial air, enabling more accurate detection of ischemic changes and improving diagnostic confidence in early postoperative MRI.

Postoperative Brain MRI After Tumor Resection: Reducing Artifacts and Improving Diagnostic Accuracy

Postoperative MRI after brain tumor surgery is often affected by artifacts caused by intracranial air, limiting reliable image interpretation.

A recent study shows that TGSE-BLADE DWI significantly reduces image distortion compared to standard RESOLVE techniques.

Using mint Lesion for quantitative analysis, researchers demonstrated near-perfect agreement with T1-weighted reference scans—resulting in improved diagnostic confidence in postoperative imaging.

What are the implications for clinical practice?

Research with mint mintLesion Neuro Therapy Response Assessment

Related Resources

Centralized Management for Clinical Trial Communications and Workflows

Requests for radiological clinical trial evaluations frequently rely on fragmented methods such as emails, phone calls, and spreadsheets. This…

mint Lesion usage during a clinical trial read, featuring the TGRM export tool.
Bridging the Gap Between RECIST and Survival: Why the FDA’s Analysis of the g Value is a Game-Changer

For decades, oncology trials have relied on RECIST 1.1 to evaluate drug efficacy. However, these categorical "snapshot" evaluations do not always…

Participants at the RECIST and Beyond workshop in Cologne during hands-on training with mint Lesion for structured tumor response assessment.
The two-day “RECIST and Beyond” workshop at radCIO Cologne offered intensive hands-on training on RECIST, iRECIST, mRECIST and LI-RADS, with real-case reporting performed directly in mint Lesion.
Successful “RECIST and Beyond” Workshop in Cologne: Advancing Precision in Oncologic Imaging

How can complex tumor findings be assessed accurately, reproducibly, and in line with clinical guidelines?